Skip to content

CarGurus, Inc. CARG Impairment Goodwill

Impairment Goodwill at other companies

Barnes Group logo
Barnes GroupB
$0
L3Harris Technologies logo
L3Harris TechnologiesLHX
$887M-43.2%
Harmonic logo
HarmonicHLIT
$14.38M
Bausch Health Companies logo
Bausch Health CompaniesBHC
$1.43B
Keurig Dr Pepper logo
Keurig Dr PepperKDP
$0-100%
Insmed logo
InsmedINSM
$0

Other financials

Income statement

See full
Revenue$243.6M+14.8%
Gross profit$224.6M+13.5%
Operating income$40.1M-20.9%
Net income$32.2M-17.5%
EPS (diluted)$0.34-8.1%

Balance sheet

See full
Cash & equivalents$72.0M-58.3%
Total debt$188.0M-3.8%
Total equity$237.1M-41.0%
Total assets$519.6M-24.6%

Cash flow

See full
Operating cash flow$69.8M+2.9%
CapEx$391.0K-82.5%
Free cash flow$69.5M+5.8%

Valuation

See full
Market cap$2.75B+6.6%
Enterprise value$2.86B+9.6%
P/E18.4×-48.1×
P/S2.9×-0.2×

Profitability

See full
Gross margin90.2%+4.0pp
Operating margin25.4%+3.4pp
Net margin15.9%+11.2pp
FCF margin31.2%+4.1pp

Returns & leverage

See full
Return on equity46.6%+38.7pp
Debt / equity0.8×+0.3×
Current ratio1.7×-1.0×

Where this comes from

Reported directly by CarGurus, Inc. in its filing.

Tagged under the XBRL concept carg:ImpairmentGoodwill.

The official record: CarGurus, Inc.’s 10-K, filed February 19, 2026, on SEC EDGAR. View the filing →

Ask your AI about CarGurus, Inc.'s impairment goodwill.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CarGurus, Inc.'s impairment goodwill?
CarGurus, Inc. (CARG) reported impairment goodwill of $4.9M in Q4 2025.
How has CarGurus, Inc.'s impairment goodwill changed year-over-year?
CarGurus, Inc.'s impairment goodwill decreased by 83.0% year-over-year, from $28.8M to $4.9M.
What does impairment goodwill mean?
Measures the loss in value of goodwill recorded on the balance sheet, typically arising from business acquisitions. It indicates that the expected future economic benefits of an acquired entity have diminished. This is a critical indicator for investors to assess the success of past M&A strategies and the current health of business units.